|
Market Closed -
Bombay S.E.
06:02:35 2026-10-28 am EDT
|
5-day change | 1st Jan Change | ||
| 30.85 INR | -3.59% |
|
-3.59% | -26.72% |
Company Valuation: Clinitech Laboratory Limited
Data adjusted to current consolidation scope
| Fiscal Period: March | 2025 | 2026 |
|---|---|---|
| Market Cap 1 | 91.84 | 79.88 |
| Change | - | -13.02% |
| Enterprise Value (EV) 1 | 61.1 | 64.14 |
| Change | - | 4.98% |
| P/E | 21.2x | 19.1x |
| PBR | 1.04x | 0.86x |
| PEG | -1.1x | -5.48x |
| Capitalization / Revenue | 1.12x | 0.84x |
| EV / Revenue | 0.74x | 0.68x |
| EV / EBITDA | 7.34x | 6.31x |
| EV / EBIT | 16x | 12.6x |
| EV / FCF | - | - |
| FCF Yield | - | - |
| Dividend per Share 2 | - | - |
| Rate of return | - | - |
| EPS 2 | 1.896 | 1.83 |
| Distribution rate | - | - |
| Net sales 1 | 82.35 | 94.91 |
| EBITDA 1 | 8.319 | 10.16 |
| EBIT 1 | 3.821 | 5.079 |
| Net income 1 | 3.947 | 4.179 |
| Net Debt 1 | -30.75 | -15.75 |
| Reference price 2 | 40.24 | 35.00 |
| Nbr of stocks (in thousands) | 2,282 | 2,282 |
| Announcement Date | 8/26/25 | 8/22/26 |
1INR in Million2INR
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 769K | |
| 13.26x | 0.4x | 8.43x | 2.92% | 117B | |
| 14.99x | 1.88x | 9.38x | 0.69% | 97.42B | |
| -286.22x | 19.97x | -337.69x | -.--% | 59.22B | |
| 14.02x | 1.53x | 9.28x | 2.52% | 29.03B | |
| 23.2x | 2.17x | 12.44x | 0.88% | 26.86B | |
| 23.49x | 2.62x | 13.31x | 1.37% | 26.69B | |
| 7.96x | 1.43x | 6.5x | -.--% | 21.1B | |
| 30.58x | 5.46x | 22.21x | 2.29% | 20.61B | |
| 30.65x | 2.87x | 12.91x | 1.47% | 16.94B | |
| Average | -14.23x | 4.26x | -27.03x | 1.35% | 41.44B | |
| Weighted average by Cap. | -26.47x | 4.29x | -39.40x | 1.48% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 544220 Stock
- Valuation Clinitech Laboratory Limited
Select your edition
All financial news and data tailored to specific country editions
